DE602005010047D1 - Nervenwachstumsfaktor sezernierende menschliche therapeutische zellen - Google Patents
Nervenwachstumsfaktor sezernierende menschliche therapeutische zellenInfo
- Publication number
- DE602005010047D1 DE602005010047D1 DE602005010047T DE602005010047T DE602005010047D1 DE 602005010047 D1 DE602005010047 D1 DE 602005010047D1 DE 602005010047 T DE602005010047 T DE 602005010047T DE 602005010047 T DE602005010047 T DE 602005010047T DE 602005010047 D1 DE602005010047 D1 DE 602005010047D1
- Authority
- DE
- Germany
- Prior art keywords
- sezernating
- growth factor
- nerve growth
- therapeutic cells
- human therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/48—Nerve growth factor [NGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/64—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/04—Immortalised cells
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200400064 | 2004-01-19 | ||
US53703304P | 2004-01-20 | 2004-01-20 | |
DKPA200400673 | 2004-04-30 | ||
US57508704P | 2004-05-28 | 2004-05-28 | |
PCT/EP2005/050180 WO2005068498A2 (en) | 2004-01-19 | 2005-01-18 | Human therapeutic cells secreting nerve growth factor |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005010047D1 true DE602005010047D1 (de) | 2008-11-13 |
Family
ID=34799654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005010047T Active DE602005010047D1 (de) | 2004-01-19 | 2005-01-18 | Nervenwachstumsfaktor sezernierende menschliche therapeutische zellen |
Country Status (7)
Country | Link |
---|---|
US (1) | US20080286323A1 (de) |
EP (1) | EP1709161B1 (de) |
AT (1) | ATE409741T1 (de) |
DE (1) | DE602005010047D1 (de) |
DK (1) | DK1709161T3 (de) |
ES (1) | ES2315842T3 (de) |
WO (1) | WO2005068498A2 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1784486T3 (da) * | 2004-06-23 | 2012-01-16 | Tissuegene Inc | Regenerering af nerver |
AU2006308312A1 (en) * | 2005-10-28 | 2007-05-03 | Nsgene A/S | Implantable Biocompatible Immunoisolatory Vehicle for Delivery of GDNF |
AU2010206374B2 (en) | 2009-01-23 | 2013-01-17 | Gloriana Therapeutics Sarl | Improved cell lines and their use in encapsulated cell biodelivery |
WO2011079222A2 (en) | 2009-12-23 | 2011-06-30 | Boston Scientific Scimed, Inc. | Less traumatic method of delivery of mesh-based devices into human body |
US8318197B2 (en) | 2011-01-18 | 2012-11-27 | Stemnion, Inc. | Wound healing device and method |
WO2012154301A1 (en) | 2011-03-18 | 2012-11-15 | Tornier, Inc. | Allogeneic microvascular tissue for soft tissue treatments |
CN104203264B (zh) | 2011-12-19 | 2018-08-28 | 瓦克化学有限公司 | 新型proNGF突变体及其在生产β-NGF中的用途 |
AU2013207346A1 (en) * | 2012-01-05 | 2014-06-05 | Beech Tree Labs, Inc. | Method of treating pain by administration of Nerve Growth Factor |
US10596202B2 (en) | 2012-09-19 | 2020-03-24 | Microvascular Tissues, Inc. | Compositions and methods for treating and preventing tissue injury and disease |
US11819522B2 (en) | 2012-09-19 | 2023-11-21 | Microvascular Tissues, Inc. | Compositions and methods for treating and preventing tissue injury and disease |
US9265458B2 (en) | 2012-12-04 | 2016-02-23 | Sync-Think, Inc. | Application of smooth pursuit cognitive testing paradigms to clinical drug development |
US9380976B2 (en) | 2013-03-11 | 2016-07-05 | Sync-Think, Inc. | Optical neuroinformatics |
WO2016036322A1 (en) | 2014-09-04 | 2016-03-10 | Kemijski inštitut | Cell-based device for local treatment with therapeutic protein |
HUE064504T2 (hu) * | 2016-03-18 | 2024-03-28 | Staidson Beijing Biopharmaceuticals Co Ltd | Idegi növekedési faktort tartalmazó fúziós fehérje, valamint elõállítási eljárása és alkalmazása |
GB201610101D0 (en) * | 2016-06-09 | 2016-07-27 | Attenborough Dental Laboratories Ltd | Multicellular lay-up process |
US20180147236A1 (en) * | 2016-11-25 | 2018-05-31 | National Taiwan University | Method of suppressing inflammation and promoting repair of injured neural tissues with carboxyl-functionalized polyurethane nanoparticles |
WO2019136455A1 (en) * | 2018-01-08 | 2019-07-11 | Microvascular Tissues, Inc. | Compositions and methods for treating nerve injury |
JP2022553849A (ja) * | 2019-11-01 | 2022-12-26 | ニューロテック ユーエスエー,インコーポレイティド | 埋め込み可能な検体拡散の機器のためのシステム、装置、機器及び方法 |
CN113845583B (zh) * | 2020-06-28 | 2023-08-11 | 江苏中新医药有限公司 | 一种修饰的重组人神经生长因子及其制备方法 |
CN114933657B (zh) * | 2021-08-25 | 2024-02-02 | 上海交通大学医学院 | 神经生长因子突变体重组蛋白及其应用 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5169762A (en) * | 1983-03-03 | 1992-12-08 | Genentech, Inc. | Human nerve growth factor by recombinant technology |
US4861719A (en) * | 1986-04-25 | 1989-08-29 | Fred Hutchinson Cancer Research Center | DNA constructs for retrovirus packaging cell lines |
US5283187A (en) * | 1987-11-17 | 1994-02-01 | Brown University Research Foundation | Cell culture-containing tubular capsule produced by co-extrusion |
US5156844A (en) * | 1987-11-17 | 1992-10-20 | Brown University Research Foundation | Neurological therapy system |
US4892538A (en) * | 1987-11-17 | 1990-01-09 | Brown University Research Foundation | In vivo delivery of neurotransmitters by implanted, encapsulated cells |
US5106627A (en) * | 1987-11-17 | 1992-04-21 | Brown University Research Foundation | Neurological therapy devices |
US5158881A (en) * | 1987-11-17 | 1992-10-27 | Brown University Research Foundation | Method and system for encapsulating cells in a tubular extrudate in separate cell compartments |
DE3829752A1 (de) * | 1988-09-01 | 1990-03-22 | Akzo Gmbh | Integrale asymmetrische polyaethersulfonmembran, verfahren zur herstellung und verwendung zur ultrafiltration und mikrofiltration |
DE3829766A1 (de) * | 1988-09-01 | 1990-03-22 | Akzo Gmbh | Verfahren zur herstellung von membranen |
DK0747485T3 (da) * | 1989-11-06 | 1999-08-16 | Cell Genesys Inc | Fremstilling af proteiner ved anvendelse af homolog rekombination |
US5272071A (en) * | 1989-12-22 | 1993-12-21 | Applied Research Systems Ars Holding N.V. | Method for the modification of the expression characteristics of an endogenous gene of a given cell line |
US5618531A (en) * | 1990-10-19 | 1997-04-08 | New York University | Method for increasing the viability of cells which are administered to the brain or spinal cord |
US5488099A (en) * | 1992-03-06 | 1996-01-30 | Persson, Deceased; Hakan B. | Multifunctional chimeric neurotrophic factors |
EP0612831B1 (de) * | 1992-12-07 | 1998-03-25 | Idemitsu Kosan Company Limited | Flammfestes Hydrauliköl |
US5512600A (en) * | 1993-01-15 | 1996-04-30 | Massachusetts Institute Of Technology | Preparation of bonded fiber structures for cell implantation |
AU688776B2 (en) * | 1993-06-23 | 1998-03-19 | Brown University Research Foundation | Method and apparatus for sealing implantable, membrane encapsulation devices |
CA2169292C (en) * | 1993-08-12 | 2010-11-23 | E. Edward Baetge | Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
US5550050A (en) * | 1994-04-15 | 1996-08-27 | Cytotherapeutics, Inc. | Method for implanting encapsulated cells in a host |
US5554146A (en) * | 1994-05-06 | 1996-09-10 | Minnesota Mining And Manufacturing Company | Mechanical fastener for disposable article |
US6299895B1 (en) * | 1997-03-24 | 2001-10-09 | Neurotech S.A. | Device and method for treating ophthalmic diseases |
US6054142A (en) * | 1996-08-01 | 2000-04-25 | Cyto Therapeutics, Inc. | Biocompatible devices with foam scaffolds |
US6303136B1 (en) * | 1998-04-13 | 2001-10-16 | Neurotech S.A. | Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane |
US6197294B1 (en) * | 1998-10-26 | 2001-03-06 | Neurotech S.A. | Cell surface molecule-induced macrophage activation |
JP3508015B2 (ja) * | 1999-12-03 | 2004-03-22 | 住友電装株式会社 | コネクタ |
-
2005
- 2005-01-18 AT AT05707792T patent/ATE409741T1/de not_active IP Right Cessation
- 2005-01-18 WO PCT/EP2005/050180 patent/WO2005068498A2/en active IP Right Grant
- 2005-01-18 ES ES05707792T patent/ES2315842T3/es active Active
- 2005-01-18 EP EP05707792A patent/EP1709161B1/de not_active Not-in-force
- 2005-01-18 DK DK05707792T patent/DK1709161T3/da active
- 2005-01-18 DE DE602005010047T patent/DE602005010047D1/de active Active
- 2005-01-18 US US10/585,811 patent/US20080286323A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1709161B1 (de) | 2008-10-01 |
ATE409741T1 (de) | 2008-10-15 |
ES2315842T3 (es) | 2009-04-01 |
WO2005068498A2 (en) | 2005-07-28 |
WO2005068498A3 (en) | 2005-09-22 |
EP1709161A2 (de) | 2006-10-11 |
DK1709161T3 (da) | 2009-01-26 |
US20080286323A1 (en) | 2008-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005010047D1 (de) | Nervenwachstumsfaktor sezernierende menschliche therapeutische zellen | |
Huang et al. | The use of balneotherapy in dermatology | |
CY1121447T1 (el) | Συνθεσεις για αυξηση δραστηριοτητας τελομερασης | |
IL291162A (en) | Isolated human rpe cells and their use for the treatment of retinal degenerative diseases | |
EP2824175A3 (de) | Mesenchymale Stammzellen und Verwendungen dafür | |
HK1145070A1 (en) | Therapeutic use of a growth factor, metrnl | |
WO2005116088A3 (en) | Methods and compositions for treating diseases and disorders associated with siglec-8 expressing cells | |
MX2010001111A (es) | Mutantes mcp-1 que antagonizan glicosaminoglicano y metodos para utilizar los mismos. | |
NZ597779A (en) | Treatment of inflammatory diseases using placental stem cells | |
DE602006017071D1 (de) | Zusammensetzungen und verfahren zur behandlung von herzkrankheiten | |
DK1641483T3 (da) | Fusionsproteiner | |
DE602004030464D1 (de) | Methode zur produktion und evaluierung der zytotoxizität von kir2dl nk-rezeptor antikörpern | |
MX2007004551A (es) | Compuestos tiadiazol y metodos de uso. | |
RS20150135A1 (en) | TREATMENT WITH ANTI-VEGF ANTIBODIES | |
CY1118073T1 (el) | Συνθεσεις και μεθοδοι για την αυξηση της δρασης της τελομερασης | |
ATE453642T1 (de) | Substituierte phenylaminopyrimidine | |
BRPI0418157A (pt) | terapêutica de tumores alogênicos | |
DE602004023183D1 (de) | Gegen antikörper gerichtete photodynamische therapie | |
EP1543158A4 (de) | Regulierte aptamer-therapeutika | |
IL174594A (en) | MANIPULATED NKT CELLS MODULATING THE Th1/Th2 BALANCE, USES AND THERAPEUTIC COMPOSITIONS THEREOF IN THE TREATMENT OF IMMUNE-RELATED DISORDERS | |
CY1109666T1 (el) | Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας | |
WO2007025229A3 (en) | Compositions and their uses directed to hsp27 | |
ATE423139T1 (de) | Natriumkanal-alpha-untereinheitsvarianten | |
CN201104532Y (zh) | 具有保健功能的拖鞋 | |
van den Hout | Enzyme Therapy in Infantyle Pompe's Disease: a clinical study of the effects of human alpha-glucosidase produced in the milk of transgenic rabbits |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |